Paquinimod

Paquinimod (订货以CAS编码或英文名称为准)

Paquinimod (ABR 25757) 是一种 S100A8/S100A9 的特异性抑制剂,通过降低 SARS-CoV-2 感染小鼠的病毒载量来用于肺炎的研究。
创赛科技提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
编号:PL11167
分子式:C21H22N2O3
CAS号:248282-01-1
分子量:350.41
申请试用
货号 品牌 规格 纯度/含量 标准价 优惠价 库存货期 数量 购买
PL11167-10mg Medlife 10mg
≥99%
¥1854.55 登录后可见
PL11167-50mg Medlife 50mg
≥99%
¥5563.64 登录后可见
PL11167-100mg Medlife 100mg
≥99%
¥9272.73 登录后可见
PL11167-200mg Medlife 200mg
≥99%
待询 登录后可见
PL11167-500mg Medlife 500mg
≥99%
待询 登录后可见
PL11167-10mM*1mLinDMSO Medlife 10mM*1mLinDMSO
≥99%
¥2040.00 登录后可见
中文名称: N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide
中文别名: N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide;帕奎莫德
英文名称: Paquinimod
英文别名: N,5-diethyl-4-hydroxy-1-methyl-2-oxo-n-phenylquinoline-3-carboxamide;UNII-HB76GLG27V;N-ethyl-N-phenyl-1,2-dihydro-5-ethyl-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide;Paquinimod [INN];N-ethyl-N-phenyl-5-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide;N-ethyl-N-phenyl-5-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide;N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-ethyl-1-methyl-2-oxo-quinoline-3-carboxamide;CHEMBL67776;SureCN1573633;Paquinimod;ABR-215757;N-ethyl-N-phenyl-5-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide;UNII-HB76GLG27V; N-ethyl-N-phenyl-1,2-dihydro-5-ethyl-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide; Paquinimod [INN]; N-ethyl-N-phenyl-5-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide; N-ethyl-N-phenyl-5-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide; N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-ethyl-1-methyl-2-oxo-quinoline-3-carboxamide; CHEMBL67776; SureCN1573633; Paquinimod; ABR-215757; N-ethy;ABR 25757;N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide;HB76GLG27V;Paquinimod; ABR 25757;ABR25757;BCP29381;ABR?215757;DB13118;SB17375;BP164809
CAS号: 248282-01-1
分子式: C21H22N2O3
分子量: 350.41
详细描述 Paquinimod (ABR 25757) 是一种 S100A8/S100A9 的特异性抑制剂,通过降低 SARS-CoV-2 感染小鼠的病毒载量来用于肺炎的研究。
搜索质检报告(COA)
相关产品